INS and Hyperinsulinemia: Because subcutaneous injection of insulin might induce higher levels of systemic insulin than endogenous insulin secretion, insulin therapy could amplify the possible relationship between hyperinsulinemia and malignancy risk by excessive insulin binding to the IGF-I receptor27.